Expand BFRI Menu
BFRI MENU

BFRI Stock Summary and Trading Ideas (Biofrontera | NASDAQ:BFRI)

Charts for Today's Stock Price and Implied Volatility in Biofrontera

22-Apr-2026

Stock Price & Volume | Full Chart

Sentiment

Trading Statistics

Key Ratios

Biofrontera (BFRI) Frequently Asked Questions

What does Biofrontera do?

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

What symbol and exchange does Biofrontera shares trade?

Biofrontera trades on the NASDAQ stock market under the symbol BFRI.

What is Biofrontera stock price doing today?

As of April 22, 2026, BFRI stock price declined to $1.06 with 89,155 million shares trading.

What is Biofrontera's Beta?

BFRI has a beta of 0.99, meaning it tends to be less sensitive to market movements. BFRI has a correlation of 0.04 to the broad based SPY ETF.

How much is Biofrontera worth?

BFRI has a market cap of $12.35 million. This is considered a Sub-Micro Cap stock.

How much money does Biofrontera make?

Last quarter Biofrontera reported $17 million in Revenue and $.48 earnings per share. This beat revenue expectation by $496,100 and exceeded earnings estimates by $.30.

What is the highest and lowest price Biofrontera traded in the last 3 year period?

In the last 3 years, BFRI traded as high as $13.42 and as low as $.54.

What are the top ETFs holding Biofrontera?

The top ETF exchange traded funds that BFRI belongs to (by Net Assets): VXF.

Is Biofrontera (BFRI) a good investment?

BFRI has underperformed the market in the last year with a return of +26.9%, while SPY returned +36.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BFRI shares. However, BFRI has outperformed the market in the last 3 month and 2 week periods, returning +6.0% and +10.4%, while SPY returned +3.5% and +5.2%, respectively. This indicates BFRI has been having a stronger performance recently.

What are the support and resistance levels for Biofrontera (BFRI)?

BFRI support price is $1.04 and resistance is $1.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BFRI shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes